Nozomi Hayakawa

7PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersSolid tumoursReproductive medicine not elsewhere classifiedCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 03, 2026
Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study.

|May 02, 2026
Editorial Comment to "Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study)".

|Jul 18, 2025
Editorial Comment to "Response to First-Line Chemotherapy Predicts Response to Maintenance Avelumab Therapy in Japanese Patients With Advanced Urothelial Carcinoma".

Nozomi Hayakawa, Eiji Kikuchi

|Apr 08, 2025
Editorial Comment to "Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study".

Nozomi Hayakawa, Eiji Kikuchi

|Mar 04, 2025
A case of multiple bone metastases during the course of non-invasive bladder and prostate cancer.

Keisuke Matsubara, Nozomi Hayakawa, Yohei Kubota

|Jul 04, 2024
Renal pelvic plasmacytoid subtype urothelial carcinoma accompanied with solitary mammary metastasis.

Keisuke Matsubara, Nozomi Hayakawa, Koichiro Aida

Pageof 2

Frequent Collaborators

5 joint publications

Eiji Kikuchi

1 joint publications

Nobuyuki Ohike

1 joint publications

Yuki Endo

1 joint publications

Yuma Sakura